HOME >> MEDICINE >> NEWS
International Study Raises Hopes For Heart Transplant Patients

Preliminary six month findings of a Multicenter International Study of the organ rejection drug, Neoral, may offer significant benefits to heart transplant recipients. Clinical results obtained from 24 research centers in five countries were reported today at the International Society For Heart and Lung Transplantation Meeting in Chicago, Illinois.

According to Howard J. Eisen, M.D., Medical Director of the Heart Transplantation Unit at Temple University Hospital, "heart transplant patients receiving Neoral experienced significantly fewer infections and a reduced number of rejections requiring antibody therapy." This two-year, double blind International Study compares the safety and effectiveness of conventional Cyclosporine A (Sandimmune) with Neoral in 380 heart transplant recipients. All patients received either Sandimmune or Neoral as part of a triple immunosuppressive regimen including steroids and azathioprine.

"Since fewer Neoral-treated patients required supplemental steroids and antibody therapy, there were also fewer infections in these heart transplant recipients," says Dr. Eisen.

In addition, lower dosages of this immunosuppressive agent were needed during the initial four weeks after treatment to achieve therapeutic blood levels. Neoral is a new formulation of Cyclosporine designed to provide increased and more reliable absorption of the medication. These findings suggest that Neoral has clinical advantages, which may translate into improved outcomes for heart transplant recipients.

In 1995, the U.S. Food and Drug Administration approved Neoral for the prevention of organ rejection. Based upon scientific registry data from the United Network for Organ Sharing (UNOS), there are currently about 3,945 patients waiting for a heart transplant. "Due to the shortage of organ donors, we need to develop new treatments to prevent organ rejection in heart transplant patients," indicates Dr. Eisen.
'"/>

Contact: Joseph J. DiBartolomeo, Ph.D.
DiBartoJ@mail.Temple.edu
215-707-4598
Temple University Health System
18-Apr-1998


Page: 1 2

Related medicine news :

1. International breast cancer prevention study launches in the United States and Canada
2. National Academies advisory: May 2 Symposium on International Science Policy
3. Awards & fellowships at the International & American Association for Dental Research General Session
4. Lectures, keynoters, symposia highlight International Dental Research meeting
5. Advances in Uterine Leiomyoma Research: 2nd NIH International Congress
6. International gathering of experts to share retinoblastoma breakthroughs
7. International trial of two microbicides begins
8. International gathering at UH examines top computer code
9. International trial finds benefits of breast MRI in women at high risk
10. International study provides culture-by-culture clues to family violence and abuse
11. St. Jude scientist wins International Society of Experimental Hematology award

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/23/2020)... , ... January 23, 2020 , ... ... Executive Committee and the IRF Board of Trustees. Representing all segments of the ... in meeting its mission of conducting research and providing education highlighting the power ...
(Date:1/23/2020)... ... January 23, 2020 , ... ... and delivered, officially launched in Orange County today with the grand opening of ... in a fraction of the time of a traditional pharmacy. NowRx uses ...
(Date:1/22/2020)... ... January 22, 2020 , ... ... speech, and education services, recently appointed Ilana Glazer as its new external ... initiatives. Specifically, Ilana directs donor relations, grants administration, external communications, community education, ...
(Date:1/22/2020)... ... January 22, 2020 , ... Dr. Mario Almanza ... can be for reducing food intake, enabling sustainable weight loss and improving patient ... bariatric surgery may be a great tool for achieving significant weight loss, it ...
(Date:1/12/2020)... ROCKVILLE, Md. (PRWEB) , ... January 11, 2020 ... ... Fund will chair a panel conversation at an event coinciding with the annual ... a morning discussion among highly experienced biotechnology, pharmaceutical and medical technology company investors ...
Breaking Medicine News(10 mins):
(Date:1/23/2020)... ... January 23, 2020 , ... EBSCO ... announced the availability of a new decision aid within its shared decision making ... to manage opioid addiction. , Opioid addiction is a chronic relapsing condition of ...
(Date:1/23/2020)... ... 23, 2020 , ... Aeroflow Healthcare, a leading durable medical ... partnership with the Idaho Physicians Network (IPN), a state-wide network of local physicians ... patients with its full suite of durable medical equipment, often available through insurance, ...
(Date:1/22/2020)... ... 2020 , ... Somatus, the market leader in providing value-based ... today announced it is expanding its renal management partnership with BlueCross BlueShield of ... kidney disease (CKD). This partnership previously only served BCBST’s Medicare Advantage members with ...
Breaking Medicine Technology:
Cached News: